(IN BRIEF) An international team of researchers has released a scientific paper through the IDAlert project, published in The Lancet Regional Health – Europe journal on August 7, 2023. Titled “Decision-Support Tools to Build Climate Resilience Against Emerging Infectious Diseases … Read the full press release
Posted in Environment, European Union, Healthcare, News, Pharma & Biotech, Science, Society
Tagged climate change, climate-driven health risks, climate-sensitive infectious diseases, Emerging Infectious Diseases, Horizon Europe, IDAlert project, infectious disease, Joacim Rocklöv, Lancet Regional Health Journal, one health, zoonosis
(PRESS RELEASE) BASEL, 12-Jan-2023 — /EuropaWire/ — Roche (SIX: RO, ROG; OTCQX: RHHBY), a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives, has announced that the European Commission has approved Xofluza (baloxavir marboxil), a … Read the full press release
Posted in Healthcare, Pharma & Biotech, Science, Switzerland
Tagged CHILDREN, infectious disease, influenza, influenza antiviral drug, Levi Garraway, oseltamivir, prevention, Roche, Xofluza treatment
Tony Wood to assume full accountability for GSK R&D in August 2022 Hal Barron to transition in August 2022 from CSO to a GSK Non-Executive Director with additional responsibilities to support R&D (PRESS RELEASE) LONDON, 19-Jan-2022 — /EuropaWire/ — GlaxoSmithKline … Read the full press release
Posted in Artificial Intelligence (AI), Healthcare, Management, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Academy of Medical Sciences, Adrestia, Altius Institute, Altos Labs, appointment, artificial-intelligence, biotechnology, Blenrep, Board of the Rosalind Franklin Institute, Cabenuva, Chief Scientific Officer, CSO, Dr. Hal Barron, Emma Walmsley, Genome Research, genomics, GlaxoSmithKline plc, GSK, immunology, Imperial College, infectious disease, Jemperli, Machine Learning, medicines, Nucala®, oncology, Pfizer, R&D, research and development, Royal Society of Biology, Royal Society of Chemistry, Tony Wood, UK National Genomics Board, University of Newcastle, Xevudy
London, United Kingdom, 10-10-2013 — /EuropaWire/ — AstraZeneca today announced that on 4 October MedImmune, its global biologics research and development arm, completed its acquisition of Amplimmune, a privately-held, US-based biologics company focused on developing novel therapeutics in cancer immunology. As previously announced, … Read the full press release
Posted in Business, Financial, Healthcare, Investment, Pharma & Biotech, United Kingdom
Tagged acquisition, Amplimmune, Anthony Brown, anti-PD-L1 mAb, AstraZeneca, autoimmune disease, Ayesha Bharmal, biologics, Cancer, cancer cells, cancer immunology, co-inhibitory molecules, co-stimulatory molecules, Colleen Proctor, Ed Seage, Esra Erkal-Paler, Gaithersburg, immune system, immune-mediated cancer therapy, IMT-C, infectious disease, Jacob Lund, Jens Lindberg, Karl Hård, MEDI-4736, MedImmune, mOX40 mAb, therapeutics, Tracy Rossin, transplantation, tremelimumab
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
